Submission Period: 10 October to 21 November 2023
Submission Rules
- all abstracts must be submitted via the online submission system (opening 10 Oct.)
- first time users (of the EMIM 2024 abstract system) need to create an account to enter the submission system (repeated users can enter with existing account)
- login data for earlier EMIMs or your member login are not valid for the EMIM 2024 submission system
- make sure that your email address for the log-in is the same as for the actual submission (author email)
- your abstract must be submitted to one of the abstract category (see below)
- size limit: all in all 2850 characters (incl. space characters) divided into:
Introduction: 600
Methods: 800
Results/Discussion: 1000
Conclusion: 450 - you strictly have to follow the scheme:
Introduction
Methods
Results
Conclusions
Acknowledgement (optional)
References (optional) - you are asked to briefly comment on the impact of your work
- declaration of financial disclosure is required
- you can add a maximum of two figures/pictures (jpeg, png) each with a limited size file of 2MB
- submissions as presenting author are limited to two (there is no limitation for co-authorship!)
- you can apply for the EMIM 2024 Young Investigator Award during submission – check eligibility criteria carefully before applying!
- you will be able to make changes on your submission until the submission deadline (21 November 2023)
- all abstracts will be acknowledged upon receipt (subject: Transmission Report). If you do not receive an automated transmission report by email please contact the helpdesk or the ESMI office
- notifications on acceptance and type of presentation (poster/talk) will be sent on 4 January 2024
Abstract Categories
- PHYSICS, ENGINEERING & TECHNOLOGIES
- Optical Technologies (Nano-, Micro-, Macroscale)
- Ultrasound & Optoacoustic Technologies
- MRS Technologies (Hyperpolarization & Multinuclear)
- MRI Physics & Hardware
- X-Ray based Technologies (incl. Synchrotron)
- Spatial Tissue Omics (incl. MassSpec, Genomics)
- PET, SPECT & Hybrid Technologies
- PROBE CHEMISTRY & REPORTER GENES
- MRI & MPI | Probes/Reporter Genes
- Optical, Optoacoustic, Ultrasound | Probes/Reporter Genes
- PET/SPECT, Radionuclide, X-Ray, CT | Probes/Reporter Genes
- Multimodal & Multiplexed Approaches | Probes/Reporter Genes
- RECONSTRUCTION, PROCESSING & ANALYSIS
- Data Analysis & AI
- Image Acquisition & Reconstruction
- IMAGE-GUIDED THERAPY
- Image-Guided Drug Delivery
- Design & Application of Theranostics
- Interventional & Surgical Imaging
- CARDIOVASCULAR & RESPIRATORY IMAGING
- Cardiac Imaging
- (Micro-) Vascular Imaging
- Pulmonary Imaging
- CNS & PERIPHERAL NERVES
- Brain (Micro-) Structure, Anatomy & Receptors
- Brain Metabolism, Function & Perfusion
- Neuroimaging Tools in Disease Models
- MUSCULOSKELETAL (no sub-category)
- GASTROINTESTINAL (no sub-category)
- ONCOLOGY
- Preclinical Studies in Cancer Therapy & Diagnosis
- Translational/Clinical Studies in Cancer Therapy & Diagnosis
- Cancer Biology
- Cancer Immunology
- New Tools to Image Cancer
- IMMUNOLOGY, INFLAMMATION & INFECTION
- Imaging the Immune System
- Imaging of Infections
- METABOLISM (no sub-category)
- ADVANCED IN VITRO MODELS & DEVELOPMENTAL BIOLOGY
- Advanced In Vitro Models (Micro to Large Scale Models)
- Developmental Biology
Technical support / Helpdesk
For any technical enquiries in regards to the EMIM 2024 abstract submission please contact EventClass
+49 (351) 30900031
email to the helpdesk
Timeline
Opening Submission: 10 October 2023
Deadline Submission: 21 November 2023
Notification to Presenters: 4 January 2024